tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Jones, 30 are a HOLD (36.59%), 5 are a SELL (6.1%), 47 are a BUY (57.32%).
Analyst Robert Jones, carries an average stock price target met ratio of 82.81% that have a potential upside of 20.5% achieved within 478 days. Previously, Robert Jones worked at GOLDMAN SACHS.
Robert Jones’s has documented 168 price targets and ratings displayed on 34 stocks. The coverage was on Healthcare, Financial Services sectors.
Most recent stock forecast was given on HCAT, Health Catalyst at 07-May-2021.
Analyst best performing recommendations are on ALHC (ALIGNMENT HEALTHCARE LLC).
The best stock recommendation documented was for ANTM (ANTHEM) at 3/4/2021. The price target of $327 was fulfilled within 1 day with a profit of $11.07 (3.5%) receiving and performance score of 35.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Feb-2018
$215
$40.04 (22.89%)
$187
2 years 11 months 24 days ago
(07-Aug-2023)
15/16 (93.75%)
$28.91 (15.54%)
636
Hold Since 27-May-2022
$190
$15.04 (8.60%)
$176
2 years 11 months 28 days ago
(03-Aug-2023)
12/12 (100%)
$-0.86 (-0.45%)
392
Buy Since 11-Oct-2022
$215
$40.04 (22.89%)
$200
2 years 11 months 28 days ago
(03-Aug-2023)
7/10 (70%)
$24.14 (12.65%)
211
Buy Since 05-Aug-2021
$220
$45.04 (25.74%)
$213
2 years 11 months 28 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
$190
$15.04 (8.60%)
2 years 11 months 29 days ago
(03-Aug-2023)
9/9 (100%)
$-0.86 (-0.45%)
440
What Year was the first public recommendation made by Robert Jones?
